Winston Medical Supply Co., Ltd. (TPEX: 6817)
Health Care · Pharmaceuticals · TW
NT$47.15
-5.23% today · -57.1% 1Y
Winston Medical Supply Co., Ltd. (TPEX: 6817) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.27M and employs 180 people.
Over the last twelve months the share price has lost 57.1%, trading between 45.50 and 114.00.
Tweenvest scores Winston Medical Supply Co., Ltd. across four factors: quality 75/100, value 88/100, dividend 90/100. Its strongest factor is dividend.
6817 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.27M
- Revenue (TTM)
- $19.89M
- P/E
- 10.54
- EPS
- 4.47
- Dividend yield
- 10.60%
- Beta (5Y)
- 0.16
- 52-week high
- NT$114.00
- 52-week low
- NT$45.50
- Avg volume (3M)
- —
- Shares outstanding
- 18.42M
- Employees
- 180
- Next earnings
- —
About Winston Medical Supply Co., Ltd.
Winston Medical Supply Co., Ltd. is a firm dedicated to the creation, production, and distribution of a wide array of pharmaceutical goods, dietary supplements, and beauty-enhancing health products. Its diverse inventory includes sterile ophthalmic formulations, such as gels, liquid suspensions, solutions, and emulsions for eye care. The company also manufactures hormonal medications, specifically contraceptives and oral suspensions designed for managing cancer-related cachexia. Additionally, its product range features topical applications, including various ointments. A significant portion of its offerings consists of diverse oral medications provided in various forms like powders, lozenges (troches), standard tablets, film-coated tablets, chewable forms, and capsules. These are developed to treat ailments such as common colds, digestive system issues, and other specific medical conditions. Established in 1974, Winston Medical Supply Co., Ltd. is based in Tainan City, Taiwan, and operates as a subsidiary of Medigen Biotechnology Corp.
- ISIN
- TW0006817000
- Founded
- 1974
- Listed since
- Feb 24, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.